Unknown

Dataset Information

0

CDKs in Sarcoma: Mediators of Disease and Emerging Therapeutic Targets.


ABSTRACT: Sarcomas represent one of the most challenging tumor types to treat due to their diverse nature and our incomplete understanding of their underlying biology. Recent work suggests cyclin-dependent kinase (CDK) pathway activation is a powerful driver of sarcomagenesis. CDK proteins participate in numerous cellular processes required for normal cell function, but their dysregulation is a hallmark of many pathologies including cancer. The contributions and significance of aberrant CDK activity to sarcoma development, however, is only partly understood. Here, we describe what is known about CDK-related alterations in the most common subtypes of sarcoma and highlight areas that warrant further investigation. As disruptions in CDK pathways appear in most, if not all, subtypes of sarcoma, we discuss the history and value of pharmacologically targeting CDKs to combat these tumors. The goals of this review are to (1) assess the prevalence and importance of CDK pathway alterations in sarcomas, (2) highlight the gap in knowledge for certain CDKs in these tumors, and (3) provide insight into studies focused on CDK inhibition for sarcoma treatment. Overall, growing evidence demonstrates a crucial role for activated CDKs in sarcoma development and as important targets for sarcoma therapy.

SUBMITTER: Kohlmeyer JL 

PROVIDER: S-EPMC7215455 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

CDKs in Sarcoma: Mediators of Disease and Emerging Therapeutic Targets.

Kohlmeyer Jordan L JL   Gordon David J DJ   Tanas Munir R MR   Monga Varun V   Dodd Rebecca D RD   Quelle Dawn E DE  

International journal of molecular sciences 20200424 8


Sarcomas represent one of the most challenging tumor types to treat due to their diverse nature and our incomplete understanding of their underlying biology. Recent work suggests cyclin-dependent kinase (CDK) pathway activation is a powerful driver of sarcomagenesis. CDK proteins participate in numerous cellular processes required for normal cell function, but their dysregulation is a hallmark of many pathologies including cancer. The contributions and significance of aberrant CDK activity to sa  ...[more]

Similar Datasets

| S-EPMC5515624 | biostudies-literature
| S-EPMC8058363 | biostudies-literature
| S-EPMC6660346 | biostudies-literature
| S-EPMC3353406 | biostudies-other
| S-EPMC7554151 | biostudies-literature
| S-EPMC5563275 | biostudies-literature
| S-EPMC9196113 | biostudies-literature
| S-EPMC8026108 | biostudies-literature
| S-EPMC4698371 | biostudies-literature
| S-EPMC7017752 | biostudies-literature